BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34702064)

  • 21. Blood Pressure Management After Endovascular Therapy for Acute Ischemic Stroke: The BEST-II Randomized Clinical Trial.
    Mistry EA; Hart KW; Davis LT; Gao Y; Prestigiacomo CJ; Mittal S; Mehta T; LaFever H; Harker P; Wilson-Perez HE; Beasley KA; Krothapalli N; Lippincott E; Stefek H; Froehler M; Chitale R; Fusco M; Grossman A; Shirani P; Smith M; Jaffa MN; Yeatts SD; Albers GW; Wanderer JP; Tolles J; Lindsell CJ; Lewis RJ; Bernard GR; Khatri P
    JAMA; 2023 Sep; 330(9):821-831. PubMed ID: 37668620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse Outcomes Associated With Higher Mean Blood Pressure and Greater Blood Pressure Variability Immediately After Successful Embolectomy in Those With Acute Ischemic Stroke, and the Influence of Pretreatment Collateral Circulation Status.
    Liu D; Nie X; Pan Y; Yan H; Pu Y; Wei Y; Cai Y; Ding Y; Lu Q; Zhang Z; Gu W; Hou X; Yang Z; Wen M; Wang P; Ma G; Ma N; Miao Z; Leng X; Yan B; Davis SM; Wang Y; Liu L
    J Am Heart Assoc; 2021 Feb; 10(5):e019350. PubMed ID: 33634704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke: The ENCHANTED Trial.
    Zhou Z; Delcourt C; Xia C; Yoshimura S; Carcel C; Torii-Yoshimura T; You S; Malavera A; Chen X; Hackett ML; Woodward M; Chalmers J; Xu J; Robinson TG; Parsons MW; Demchuk AM; Lindley RI; Mair G; Wardlaw JM; Anderson CS
    Neurology; 2021 Mar; 96(11):e1512-e1526. PubMed ID: 33536271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial.
    Chen G; Wang X; Robinson TG; Pikkemaat M; Lindley RI; Zhou S; Ping L; Liu W; Liu L; Chalmers J; Anderson CS;
    J Neurol Sci; 2018 Apr; 387():1-5. PubMed ID: 29571842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
    Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants.
    Okada T; Yoshimoto T; Wada S; Yoshimura S; Chiba T; Egashira S; Kimura S; Shiozawa M; Inoue M; Ihara M; Toyoda K; Takashima H; Koga M
    J Am Heart Assoc; 2022 Oct; 11(19):e025809. PubMed ID: 36129032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.
    Pancioli AM; Adeoye O; Schmit PA; Khoury J; Levine SR; Tomsick TA; Sucharew H; Brooks CE; Crocco TJ; Gutmann L; Hemmen TM; Kasner SE; Kleindorfer D; Knight WA; Martini S; McKinney JS; Meurer WJ; Meyer BC; Schneider A; Scott PA; Starkman S; Warach S; Broderick JP;
    Stroke; 2013 Sep; 44(9):2381-7. PubMed ID: 23887841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early decompressive hemicraniectomy in thrombolyzed acute ischemic stroke patients from the international ENCHANTED trial.
    Xia C; Wang X; Lindley RI; Delcourt C; Chen X; Zhou Z; Guo R; Carcel C; Malavera A; Calic Z; Mair G; Wardlaw JM; Robinson TG; Anderson CS
    Sci Rep; 2021 Aug; 11(1):16495. PubMed ID: 34389772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolysis Outcomes in Acute Ischemic Stroke by Fluid-Attenuated Inversion Recovery Hyperintense Arteries.
    Zhou Z; Yoshimura S; Delcourt C; Lindley RI; You S; Malavera A; Torii-Yoshimura T; Carcel C; Wang X; Chen X; Parsons MW; Demchuk AM; Wardlaw JM; Mair G; Robinson TG; Chalmers J; Xu J; Anderson CS
    Stroke; 2020 Jul; 51(7):2240-2243. PubMed ID: 32568636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Blood Pressure and Blood Pressure-Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke.
    Berge E; Cohen G; Lindley RI; Sandercock P; Wardlaw JM; Sandset EC; Whiteley W
    Stroke; 2015 Dec; 46(12):3362-9. PubMed ID: 26486868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnitude of Systolic Blood Pressure Reduction and Early Achieved Blood Pressure and Clinical Outcomes After Acute Ischemic Stroke.
    Zhai Y; Shi M; Liu Y; Peng Y; Zhu Z; Wang A; Peng H; Xu T; Chen J; Xu T; Zhang Y; He J; Zhong C
    J Am Heart Assoc; 2023 Oct; 12(20):e030692. PubMed ID: 37804202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.
    Dong Y; Han Y; Shen H; Wang Y; Ma F; Li H; Wang Y; Dong Q
    Stroke Vasc Neurol; 2020 Dec; 5(4):348-352. PubMed ID: 32611728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined utility of blood glucose and white blood cell in predicting outcome after acute ischemic stroke: The ENCHANTED trial.
    Xia C; Wang X; Lindley RI; Delcourt C; Zhou Z; Chen X; Carcel C; Malavera A; Calic Z; Anderson CS;
    Clin Neurol Neurosurg; 2020 Nov; 198():106254. PubMed ID: 33011482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic Resonance Imaging-Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size: THAWS RCT Substudy.
    Toyoda K; Inoue M; Yoshimura S; Yamagami H; Sasaki M; Fukuda-Doi M; Kimura K; Asakura K; Miwa K; Kanzawa T; Ihara M; Kondo R; Shiozawa M; Ohtaki M; Kamiyama K; Itabashi R; Iwama T; Aoki J; Minematsu K; Yamamoto H; Koga M;
    Stroke; 2021 Jan; 52(1):12-19. PubMed ID: 33297866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline Blood Pressure Effect on the Benefit and Safety of Intra-Arterial Treatment in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands).
    Mulder MJHL; Ergezen S; Lingsma HF; Berkhemer OA; Fransen PSS; Beumer D; van den Berg LA; Lycklama À Nijeholt G; Emmer BJ; van der Worp HB; Nederkoorn PJ; Roos YBWEM; van Oostenbrugge RJ; van Zwam WH; Majoie CBLM; van der Lugt A; Dippel DWJ;
    Stroke; 2017 Jul; 48(7):1869-1876. PubMed ID: 28432266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Admission blood pressure and clinical outcomes in patients with acute ischaemic stroke treated with intravenous alteplase and endovascular treatment versus endovascular treatment alone: A MR CLEAN-NO IV substudy.
    van den Berg SA; Uniken Venema SM; LeCouffe NE; Postma AA; Lycklama À Nijeholt GJ; Rinkel LA; Treurniet KM; Kappelhof M; Bruggeman AE; van Kranendonk KR; Majoie CB; Dippel DW; van der Worp HB; Coutinho JM; Nederkoorn PJ; Roos YB
    Eur Stroke J; 2023 Sep; 8(3):647-654. PubMed ID: 37641554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry.
    Robinson TG; Bray BD; Paley L; Sprigg N; Wang X; Arima H; Bath PM; Broderick JP; Durham AC; Kim JS; Lavados PM; Lee TH; Martins S; Nguyen TH; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sharma VK; Wang J; Woodward M; Rudd AG; Chalmers J; S Anderson C;
    Int J Stroke; 2019 Oct; 14(7):678-685. PubMed ID: 30961463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
    Zhong CS; Beharry J; Salazar D; Smith K; Withington S; Campbell BCV; Wilson D; Le Heron C; Mason D; Duncan R; Reimers J; Mein-Smith F; Diprose WK; Barber PA; Ranta A; Fink JN; Wu TY
    Stroke; 2021 Mar; 52(3):1087-1090. PubMed ID: 33588597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of 24 h Blood Pressure on Functional Outcome in Patients with Acute Ischemic Stroke Post Intravenous Thrombolysis.
    Reddy S; Paramasivan NK; Sreedharan SE; Sukumaran S; Vinoda Thulaseedharan J; Sylaja PN
    Cerebrovasc Dis; 2023; 52(2):177-183. PubMed ID: 36423595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke.
    Tsivgoulis G; Saqqur M; Sharma VK; Lao AY; Hill MD; Alexandrov AV;
    Stroke; 2007 Mar; 38(3):961-6. PubMed ID: 17255548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.